MedPath

Effects of Intense Aerobic Exercise on the Cerebrovascular Reserve Capacity in Patients With Hemodynamically Relevant Intra- and Extracranial Stenoses

Not Applicable
Terminated
Conditions
Stenosis
Interventions
Behavioral: Intense aerobic exercise
Registration Number
NCT00912561
Lead Sponsor
Gerhard Jan Jungehuelsing
Brief Summary

The purpose of this trial is to study the improvement of cerebral hemodynamics in high risk stroke patients with impaired Cerebrovascular Reserve (CVR) due to high grade stenosis of the internal carotid (ICA) or middle cerebral artery (MCA) by Intense Aerobic Exercise (IAEx).

Detailed Description

The primary objective: Intense aerobic exercise (24/8 weeks) improves CVR \> 20% measured by Transcranial Doppler (TCD) in patients with hemodynamic relevant intra- or extracranial stenoses by enhanced cerebral arterio- and angiogenesis.

Secondary objectives:

Intense aerobic exercise (24/8 weeks) leads to:

* an increase of Endothelial progenitor cell counts (EPCs)

* qualitative and quantitative changes of endothelial markers and cytokines representing the inflammatory activity of atherosclerosis and neovascularisation

* an improvement in cognitive performance and quality of life (QoL)

* changes of the mean vessel size and of cerebral perfusion

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • high-grade stenosis of the intra- or extracranial ICA or the MCA with ipsilateral impairment of the CVR capacity measured by TCD
Exclusion Criteria
  • continuous physical activity ≥ 60 min/week within the last 3 months
  • cerebral bleeding or ischaemic stroke < 3 months
  • contraindications for spiro-ergometry, IAEx, or MRI

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
patients who train immediately after enrollmentIntense aerobic exercisepatients who train immediately after enrollment
Primary Outcome Measures
NameTimeMethod
change of cerebrovascular reserve capacityimmediately after intervention of 8 weeks, 3 months, 6 months, 12 months Follow up
Secondary Outcome Measures
NameTimeMethod
Endothelial Progenitor Cells, cyto- and chemokinesafter intervention of 8 weeks, 3 months, 6 months, 12 months Follow up
Neuropsychological Testing/ Quality of lifeimmediately after intervention of 8 weeks, 3 months, 6 months, 12 months Follow up

Trial Locations

Locations (1)

Centre for Stroke Research Berlin, Neurology, Charité Campus Benjamin Franklin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath